Oppenheimer & Co’s Hologic HOLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-19,020
| Closed | -$1.44M | – | 1803 |
|
|
2026
Q1 | $1.44M | Sell |
19,020
-1,925
| -9% | -$145K | 0.02% | 717 |
|
|
2025
Q4 | $1.56M | Sell |
20,945
-755
| -3% | -$55.2K | 0.02% | 617 |
|
|
2025
Q3 | $1.46M | Sell |
21,700
-1,557
| -7% | -$103K | 0.02% | 719 |
|
|
2025
Q2 | $1.52M | Sell |
23,257
-176
| -0.8% | -$10.5K | 0.02% | 675 |
|
|
2025
Q1 | $1.45M | Buy |
23,433
+2,208
| +10% | +$146K | 0.02% | 654 |
|
|
2024
Q4 | $1.53M | Buy |
21,225
+1,250
| +6% | +$97.7K | 0.02% | 637 |
|
|
2024
Q3 | $1.63M | Sell |
19,975
-300
| -1% | -$24K | 0.02% | 614 |
|
|
2024
Q2 | $1.51M | Buy |
20,275
+500
| +3% | +$37.5K | 0.02% | 623 |
|
|
2024
Q1 | $1.54M | Buy |
19,775
+750
| +4% | +$55.8K | 0.03% | 597 |
|
|
2023
Q4 | $1.36M | Buy |
19,025
+4,625
| +32% | +$322K | 0.03% | 617 |
|
|
2023
Q3 | $999K | Buy |
14,400
+564
| +4% | +$42.6K | 0.02% | 676 |
|
|
2023
Q2 | $1.12M | Sell |
13,836
-264
| -2% | -$21.6K | 0.02% | 660 |
|
|
2023
Q1 | $1.14M | Sell |
14,100
-21,697
| -61% | -$1.75M | 0.02% | 645 |
|
|
2022
Q4 | $2.68M | Buy |
35,797
+23,132
| +183% | +$1.65M | 0.06% | 362 |
|
|
2022
Q3 | $817K | Buy |
12,665
+269
| +2% | +$18.6K | 0.02% | 719 |
|
|
2022
Q2 | $859K | Buy |
12,396
+517
| +4% | +$38.4K | 0.02% | 740 |
|
|
2022
Q1 | $913K | Buy |
11,879
+5,413
| +84% | +$389K | 0.02% | 776 |
|
|
2021
Q4 | $495K | Sell |
6,466
-24,583
| -79% | -$1.81M | 0.01% | 1033 |
|
|
2021
Q3 | $2.29M | Buy |
31,049
+1,432
| +5% | +$107K | 0.04% | 467 |
|
|
2021
Q2 | $1.98M | Buy |
29,617
+22,944
| +344% | +$1.53M | 0.04% | 523 |
|
|
2021
Q1 | $496K | Buy |
+6,673
| New | +$507K | 0.01% | 969 |
|
|
2017
Q1 | – | Sell |
-6,952
| Closed | -$279K | – | 1312 |
|
|
2016
Q4 | $279K | Buy |
+6,952
| New | +$268K | 0.01% | 1024 |
|
|
2016
Q3 | – | Sell |
-6,127
| Closed | -$212K | – | 1286 |
|
|
2016
Q2 | $212K | Sell |
6,127
-198
| -3% | -$6.86K | 0.01% | 1076 |
|
|
2016
Q1 | $218K | Hold |
6,325
| – | – | 0.01% | 1067 |
|
|
2015
Q4 | $245K | Buy |
+6,325
| New | +$246K | 0.01% | 1035 |
|
Other funds holding HOLX
Oppenheimer & Co's HOLX Position: Q2 2026 in Review
Oppenheimer & Co sold out of Hologic (HOLX) in Q2 2026, closing a stake of 19,020 shares — an estimated $1.44M sold.
Oppenheimer & Co first reported a position in HOLX in Q4 2015 and held it in 25 quarters. The position peaked at $2.68M in Q4 2022. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.
- Oppenheimer & Co reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
- Oppenheimer & Co sold 19,020 Hologic shares in Q2 2026, an estimated $1.44M.
- Oppenheimer & Co first reported a position in Hologic in Q4 2015 and held it in 25 quarters.
- Oppenheimer & Co's Hologic position peaked at $2.68M in Q4 2022.
- 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.
Based on Oppenheimer & Co's 13F filing for Q2 2026, filed 3 Aug 2026.